Kinase Reaction of Lapatinib (IMAGE) University of North Carolina Health Care Caption When the drug lapatinib inhibits the expression of the HER2 kinase in five different HER2-positive breast cancer cell lines, other kinases are also tamped down (blue) but several more kinases are activated (red), leading to drug resistance and tumor growth. Credit Tim Stuhlmiller, PhD, UNC School of Medicine Usage Restrictions Credit properly License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.